This federal contract award is for the supply of the pharmaceutical product Gadavist (7.5 mmol/7.5 ml vial, 7.5 ml) to the Defense Logistics Agency (DLA). The $1,071.13 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and does not have a set-aside designation. The contract has an ultimate completion date of September 13, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a range of medical commodities to military treatment programs and facilities worldwide.
Generated 12/12/24, 9:15 AM